Reassessment of the reimbursement status of blood pressure products resumed in the Reimbursement Committee
At its meeting on 12 December 2006 , the Reimbursement Committee resumed the reassessment of the reimbursement status of blood pressure products. The Committee discussed a range of aspects and it will begin working on a draft recommendation. Material from the Committee meetings is available via the fact box to the right.
For further information, please contact the Reimbursement Section, email@example.com.
The Danish Medicines Agency, 15 December 2006